Influence of surgical manipulation and surgical modality on the molecular detection of circulating tumor cells from colorectal cancer by Park, Soo Yeun et al.
Copyright © 2012, the Korean Surgical Society




Journal of the Korean Surgical Society
 pISSN 2233-7903ㆍeISSN 2093-0488
Received November 2, 2011, Revised February 27, 2012, Accepted March 12, 2012
Correspondence to: Gyu-Seog Choi
Department of Surgery, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, 807 
Hoguk-ro, Buk-gu, Daegu 702-210, Korea
Tel: ＋82-53-200-2166, Fax: ＋82-53-200-2027, E-mail: kyuschoi@mail.knu.ac.kr
cc  Journal of the Korean Surgical Society is an Open Access Journal. All articles are distributed under the terms of the Creative Commons 
Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, 
distribution, and reproduction in any medium, provided the original work is properly cited.
Influence of surgical manipulation and surgical modality 
on the molecular detection of circulating tumor cells 
from colorectal cancer
Soo Yeun Park, Gyu-Seog Choi, Jun Seok Park, Hye Jin Kim, Jong-Pil Ryuk, Whon-Ho Choi
Colorectal Cancer Center, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, 
Daegu, Korea
Purpose: The aim of this study was to evaluate the relationship between the detection of circulating tumor cell molecular 
markers from localized colorectal cancer and the time-course of a surgical manipulation or surgical modality. Methods: From 
January 2010 to June 2010, samples from the peripheral blood and the inferior mesenteric vein were collected from 42 pa-
tients with cancer of the sigmoid colon or rectum. Pre-operative, intra-operative (both pre-mobilization and post-mobi-
lization), and post-operative samples were collected. We examined carcinoembryonic antigen (CEA) mRNA and cytoker-
atin-20 (CK20) mRNA by real-time reverse-transcriptase polymerase chain reaction. Changes in mRNA detection rates were 
analyzed according to the time of blood sample collection, the surgical modality, and patient clinicopathological features. 
Results: mRNA expression rates before surgical resection did not differ between blood samples from the peripheral and in-
ferior mesenteric veins. The detection rate for CEA and CK20 mRNA showed a tendency to increase after operative mobi-
lization of the cancer-bearing bowel segment. Furthermore, the cumulative detection rates for CEA and CK20 mRNA in-
creased significantly over the course of surgery (pre-mobilization vs. post-mobilization). The cumulative detection rate de-
creased significantly after surgical resection compared with the pre-operative rates. However, no significant difference was 
observed in the detection rates between different surgical modalities (laparoscopy vs. open surgery). Conclusion: The results 
of this study suggest that surgical manipulation has a negative influence on the dissemination of circulating tumor cells dur-
ing operations on localized colorectal cancer. However, the type of surgical technique did not affect circulating tumor cells.
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INTRODUCTION
Although advances in treatment modalities have im-
proved, the survival rate of patients with colorectal cancer 
(CRC) after surgical removal, 30 to 50% of patients with 
CRC develop a recurrence following complete surgical re-
section of a primary tumor [1,2]. Distant metastasis 
through the hematogenous and lymphatic pathways is a 
major cause of disease recurrence, which has a substantial 
impact on patient prognosis. Micrometastasis is assumed Surgical manipulation and circulating tumor cell
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Fig. 1. Time-frame for collecting blood sample. PV, peripheral vein; IMV, inferior mesenteric vein.
to be the cause of metastasis in patients who have under-
gone curable surgical resection. Hematogenous micro-
metastasis has been studied in circulating tumor cells 
(CTCs), which shed from the primary tumor, spread 
through the blood stream, invade distant organs, and re-
sult in distant metastasis [3]. CTCs in patients with CRC 
were first detected in 1955, and many studies thereafter 
have focused on detecting CTCs and their clinical im-
plications for patients with CRC [4].
Animal studies have shown that malignant cells are 
shed into the blood stream during surgical manipulation 
of a primary tumor [5,6]. Minimal manipulation of the ma-
lignant lesion is a generally accepted concept to reduce 
these micrometastases during surgery. Fisher and Turnbull 
[7] suggested that tumor cells are scattered by surgical 
manipulation. “No-touch isolation”, a surgical technique 
involving early lymphovascular ligation before tumor ma-
nipulation, has been proposed to minimize micrometa-
stasis during an operation [8,9]. However, few reports 
have examined the presence of free cancer cells in blood 
samples in relation to the whole time-course of surgery or 
analyzed the relationship between surgical manipulation 
and the detection of CTCs. Furthermore, it remains un-
clear whether the surgical modality (laparoscopy vs. open 
surgery) differently affects CTC detection.
Development of a reliable detection method is essential 
to understand the mechanisms and implication of CTCs. 
The reverse-transcriptase polymerase chain reaction (RT- 
PCR) technique was developed to enable the detection of a 
small number of cancer cells, which is not possible with cy-
tology or immunological techniques. Moreover, real-time 
RT-PCR can be used to monitor the low-level expression of 
marker mRNAs and establish cut-off values. This techni-
que has been used to detect disseminated tumor cells in 
the peripheral blood, bone marrow, and peritoneal lavage 
of patients with CRC by detecting epithelial marker 
mRNAs [10]. The most reliable RT-PCR targets in CRC are 
cytokeratins (CKs), and carcinoembryonic antigen (CEA).
In the present study, we used real-time RT-PCR to detect 
CEA and CK20 mRNA expression in the peripheral and 
inferior mesenteric vein (IMV) in relation to the time-course 
of CRC surgery. The purpose of the study was to assess the 
influence of surgical manipulation and two different sur-
gical modalities on the presence of CTC markers in pa-
tients with curable CRC.
METHODS
Study patients
This study involved 53 consecutive patients with CRC 
who underwent potentially curative surgical resection in a 
single CRC center between January 2010 and June 2010. 
Enrolled patients had been diagnosed with primary CRC, 
which was confirmed by colonoscopic biopsy. Cancer lo-
cation was limited to the sigmoid colon and rectum. 
Patients underwent either laparoscopic or open surgery. 
None of the patients received chemotherapy or radiation 
therapy before surgery. Patients with palliative resection, 
prior endoscopic mucosal resection, distant metastasis, 
need for an emergency operation, age ＞80 years, and 
American Society of Anesthesiology score ＞3 points were 
also excluded. This study was conducted prospectively af-
ter gaining approval from the local Institutional Review 
Boards. All patients provided written informed consent.
Blood sample collection
Samples from the peripheral blood and the IMV were Soo Yeun Park, et al.
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Fig. 2. Blood samples from the inferior mesenteric vein were 
obtained by direct puncture with a 23-gauge needle.
collected from patients at four different time-points dur-
ing the peri-operative period (Fig. 1). Blood from the pe-
ripheral vein was extracted just before skin incision 
(pre-operation) and immediately after closure of skin in-
cision (post-operation). During the operation, blood sam-
ples from the IMV were obtained (pre-mobilization) be-
fore beginning the manipulation of the cancer-bearing 
bowel segment. Blood samples from the IMV were ob-
tained by direct puncture of the vein with a 23-gauge nee-
dle, and the vein was then ligated (Fig. 2). After mobilizing 
the cancer-bearing bowel and dividing the distal margin, 
post-mobilization samples were collected from the IMV 
distal from the ligation prior to cancer removal. To prevent 
any contamination of epithelial cells, the initial 10 mL of 
blood was discarded from all blood samples and the fol-
lowing 10 mL of blood, drawn using a new syringe, was 
used for RNA extraction.
Real-time RT-PCR
Five mL blood samples were collected in ethylenedia-
minetetraacetic acid-containing tubes. Three mL of whole 
blood was transferred to a 15 mL conical centrifuge tube 
with the same volume of Histopaque-10771 separation 
medium (Sigma-Aldrich Co., St. Louis, MO, USA) and 
centrifuged at 400 × g at room temperature for 30 minutes. 
Cells at the interface were transferred to a clean conical 
centrifuge tube and washed with 10 mL of phosphate-buf-
fered saline (PBS) or appropriate cell culture medium. 
After the cells were centrifuged with washing buffer at 250 
× g for 10 minutes, the supernatant was aspirated and 
discarded. Pelleted cells were resuspended in 5 mL of iso-
tonic PBS solution and mixed by gently drawing the sol-
ution with a Pasteur pipette.
Total RNA was extracted by using Trizol reagent (15596- 
18; Invitrogen, Carlsbad, CA, USA), according to the man-
ufacturer’s protocol. The volume of total RNA obtained 
was checked spectrophotometrically at 260 nm using a 
Nanodrop spectrophotometer (Thermo Fisher Scientific 
Inc., Rockford, IL, USA). Reverse transcription was con-
ducted in a reaction mixture consisting of 10 × RT buffer (2 
μL), 25 × dNTP mix (0.8 μL), 10 × RT random primers (2 
μL), RNase inhibitor (1 μL), distilled water (3.2 μL), and 10 
μL RNA (100 ng/μL). The reaction mixture was incubated 
for 10 minutes at 25
oC, 120 minutes at 37
oC, heated to 85
oC 
for 5 minutes, and then stored at -20
oC until analysis. The 
integrity of the isolated RNA was established by real 
time-PCR analysis of the housekeeping gene, glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH).
Real time-PCR reactions of CEA, CK20, and GAPDH 
were performed on an ABI 7500 Real-Time PCR system 
(Applied Biosystems, Foster City, CA, USA). Primers and 
probes were synthesized by Applied Biosystems. Real-time 
PCR reactions were prepared using TaqMan probe, a pri-
mer set for CEA (Hs00944025_m1), CK20 (Hs00300643_ 
m1), and GAPDH (Hs99999905_m1), TaqMan Gene Ex-
pression Master Mix (ABI. 4369016), a MicroAmp optical 
96-well reaction plate (ABI. N8010560), and MicroAmp 
optical adhesive film (ABI. 4311971). The thermocycling 
conditions were as follows: 50
oC for 2 minutes, 95
oC for 10 
minutes, followed by 43 cycles at 95
oC for 15 seconds, and 
60
oC for 1 minute. Data were analyzed with SDS relative 
quantification software ver. 2.2.3 (Applied Biosystems), 
using the automatic cycle threshold setting for assigning 
the baseline and threshold for positive results. The thresh-
old for the epithelial tumor markers of CRC CTC has been 
reported as 35 to 50 cycles according to an individualized 
assay [11]. The patients were considered to have CTCs if 
mRNA was detected after 36 to 40 PCR cycles (threshold 
cycle value, Ct), which was determined through our in-
dividualized pilot study. Samples from 10 healthy volun-Surgical manipulation and circulating tumor cell
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Table 1. Clinicopathologic characteristics of all patients and 
comparison between mRNA (CEA or CK20) expression-positive 
and -negative patients, based on samples collected at the 
post-mobilization time-point




a) 63.4 (11.5) 62.6 (12.1) 66.33 (8.9) 0.191
Sex 0.676
 Male  31 (73.8) 25 (80.6) 6 (19.4)




2.9 (4.0) 3.1 (4.3) 2.1 (2.6) 0.364
Tumor site 0.716
 Sigmoid colon 17 (40.5) 14 (82.4) 3 (17.6)
 Rectum 25 (59.5) 19 (76.0) 6 (24.0)
Tumor size (cm)
a) 4.3 (1.9) 4.2 (1.8) 4.4 (2.7) 0.695
Differentiation 0.387
 Well 0 (0) 0 (0) 0 (0)
 Moderate 40 (95.2) 32 (80.0) 8 (20.0)
 Poor 2 (4.8) 1 (50.0) 1 (50.0)
Depth of invasion 0.655
 T1-T2 9 (21.4) 8 (88.9) 1 (11.1)
 T3-T4 33 (78.6) 25 (75.8) 8 (24.2)
Lymphatic invasion 0.561
 Absent 38 (90.5) 29 (76.3) 9 (23.7)
 Present 4 (9.5) 4 (100.0) 0 (0)
Venous invasion 1.000
 Absent 42 (100) 33 (100.0) 9 (100.0)
 Present 0 (0) 0 (0) 0 (0)
Stage 0.139
 I 7 (16.7) 6 (85.7) 1 (14.3)
 II 20 (47.6) 13 (65.0) 7 (35.0)
 III 15 (35.7) 14 (93.3) 1 (6.7)
CEA, carcinoembryonic antigen; CK20, cytokeratin-20.
a)Values are presented as mean (SD).
teers and dextrose solution from which no mRNA was de-
tected even after more than 45 to 48 cycles served as neg-
ative controls. The PCR products were confirmed by 2% 
agarose gel electrophoresis. Real time-PCR was evaluated 
by independent investigators unaware of patient status.
Statistical analysis
Changes in these mRNA levels were analyzed accord-
ing to collection time, surgical modality, and patient clin-
icopathological features. Statistical calculations were per-
formed using SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA). 
The McNemar test was used to examine differences be-
tween the detection rate in peripheral and IMV blood. 
Statistical differences between pre- and post-operative 
positive rates for mRNA markers were calculated with the 
chi-square test. The chi-square and Fisher’s exact tests 
were used to compare clinicopathological parameters be-
tween mRNA marker-positive patients and mRNA-neg-
ative patients at the post-mobilization time-point. The 
Mann-Whitney U-test was used to compare continuous 
variables. Statistical significance was set at P ＜  0.05.
RESULTS
Fifty-three patients were included in the study. Sampl-
ing from the IMV before or after bowel mobilization failed 
in 11 patients. The remaining 42 patients were included in 
the analysis. The clinicopathological characteristics of all 
patients, including age, gender, tumor size, location, stage, 
and lymph node metastasis, are summarized in Table 1. 
The mean age of the patients was 63.4 years. Of all patients, 
17 had sigmoid colon cancer and 25 had rectal cancer. 
Forty patients had moderately differentiated and two had 
poorly differentiated carcinomas. Based on the tumor- 
node-metastasis classification of resected specimens, seven 
patients had stage I, 20 had stage II, and 15 had stage III 
cancer. Comparison between mRNA-positive patients 
and -negative patients at the post-mobilization stage 
showed no significant differences in the clinicopatho-
logical characteristics between the two groups. The 
mRNA expression at the post-mobilization time-point 
was not significantly different with regard to the overall 
operation time and intra-operative blood loss. A compar-
ison between the laparoscopic and the open surgery 
groups showed no differences in the clinicopathological 
characteristics, except tumor size, which was greater in the 
open surgery group.
CEA and CK20 mRNA expression before surgery was 
similar in blood samples from the periphery and the IMV. 
CEA mRNA was identified in 28.6% of peripheral samples 
and 19.0% of IMV samples before surgery. The expression 
rates showed 66.6% consistency between blood from the 
periphery and IMVs. CK20 mRNA was identified in 50.0% 
of peripheral samples and 52.3% of IMV samples. The 
CK20 mRNA expression rates showed a 64.3% consistency Soo Yeun Park, et al.
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Fig. 3. Comparison of circulating tumor markers (sampled from the 
inferior mesenteric vein) between the pre-mobilization and post- 
mobilization time-points. CEA, carcinoembryonic antigen; CK20, 
cytokeratin-20. 
a)P ＜  0.05.
Fig. 5. Comparison of circulating tumor markers (sampled from the 
peripheral vein) between the pre-operative and post-operative day 
4 time-points. CEA, carcinoembryonic antigen; CK20, cytoke-
ratin-20.
Fig. 4. Comparison of circulating tumor markers (sampled from the 
peripheral vein) between the pre-operative and post-operative 
time-points. CEA, carcinoembryonic antigen; CK20, cytoke-
ratin-20. 
a)P ＜  0.05.
Table 2. Comparison of circulating tumor markers between 






 CEAp (pre-operative) 33.3% 20.0% 0.485
CEAi (pre-mobilization) 25.9% 20.0% 1.000
CEAi (post-mobilization) 51.9% 53.3% 0.927
CEAp (post-operative) 22.2% 13.3% 0.689
CK 20p (pre-operative) 44.4% 60.0% 0.334
CK 20i (pre-mobilization) 44.4% 66.7% 0.167
CK 20i (post-mobilization) 59.3% 60.0% 0.963
CK 20p (post-operative) 48.1% 33.3% 0.353
CEA, carcinoembryonic antigen; CK20, cytokeratin-20; p, blood 
sampled from the peripheral blood; i, blood sampled from the 
inferior mesenteric vein.
between blood from the periphery and that from IMVs.
Comparison of samples from the IMV between before 
and after mobilization showed that the detection rate of 
CEA mRNA increased after mobilization (P = 0.07) (Fig. 3). 
The CK20 mRNA detection rate did not differ between 
pre- and post-mobilization samples. Cumulative detection 
rates were calculated to assess overall detection rates, re-
sulting in a score ranging from 0 (mRNA-negative for both 
markers) to 1 (positive for at least one marker). The cumu-
lative detection rates increased significantly after surgical 
manipulation (P = 0.032).
Comparing the samples from peripheral blood between 
the pre-operative and post-operative time-points revealed 
that the cumulative detection rates decreased significantly 
after surgical resection (P = 0.027). The detection rate for 
each individual mRNA also tended to decrease after oper-
ation compared with that before surgery, but without stat-
istical significance (CEA mRNA, P = 0.306; CK20 mRNA, P 
= 0.512) (Fig. 4). Comparing peripheral blood samples be-
tween the post-operative time-point and post-operative 
day 4 showed that the detection rate for mRNA markers 
did not decrease significantly (Fig. 5).
To assess the effect of surgical modality, detection rates 
for both mRNAs were compared between the laparo-
scopic and open surgery groups. No differences in the de-
tection rate were observed for either of the two markers in 
relation to the surgical modality (laparoscopy vs. open 
surgery) at any time-point (Table 2). The cumulative de-
tection rate also showed no significant difference between 
the two surgery groups.Surgical manipulation and circulating tumor cell
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DISCUSSION
The present study showed that the presence of CEA and 
CK20 mRNA was similar in both peripheral blood and 
mesenteric blood, and that mRNA detection rate in-
creased after surgical manipulation of the cancer-bearing 
bowel segment. Expression of both mRNAs decreased af-
ter completion of the surgery. The detection rate of the 
CTC markers was not affected by surgical modality 
(laparoscopy vs. open surgery).
In the past, detection of CTCs in the blood of patients 
with cancer was achieved by cytology, immunocytoche-
mistry, and flow cytometry techniques. As the number of 
cells in the blood is as low as one CTC in 10
5 to 10
7 leuko-
cytes, these techniques have a high specificity but limited 
sensitivity [11]. PCR techniques can detect trace amounts 
(1/10
6) of cells in peripheral blood, lymph nodes, cere-
brospinal fluid, and bone marrow [12]. The advantage of 
identifying RNA is that this technique implies that the cell 
is viable, because extracellular RNA is rapidly degraded, 
and only viable cells produce mRNA [13]. Therefore, cur-
rent studies usually use RT-PCR techniques. CKs (such as 
CK20 and CK19), and CEA are the most commonly used 
RT-PCR markers for CRC. In the present study, we applied 
the RT-PCR assay to examine CEA and CK20 mRNA as 
surrogate markers to detect CRCs in the blood of patients 
with CRC. Great variability in CTC detection rates has 
been observed across studies, ranging from 4 to 57% in 
stage I to III CRC patients [14,15]. These variable detection 
rates are caused by technical errors, different sampling 
time-points, and using different veins for sampling. We 
used two different mRNA markers and samples taken at 
four time-points based on the surgical procedure to mini-
mize variability. We observed that CEA mRNA was de-
tected in 28.6% of samples, whereas the CK20 mRNA de-
tection rate was 50.0% from peripheral blood during 
pre-operative state.
Surgical manipulation has been suggested to be an ag-
gravating factor for tumor dissemination. The impact of 
surgical manipulation on oncological outcome can be ap-
proached based on long-term oncological results (survival 
and recurrence), but the direct effect of surgery can be as-
sessed by detecting free cancer cells in the blood. In animal 
studies, detached cancer cells resulting from surgical ma-
nipulation are associated with blood-borne metastases [6]. 
Several human studies have also shown an association be-
tween surgical manipulation and CTC dissemination. 
Intra-operative dissemination of free cancer cells during 
resection of colorectal liver metastases was a significant 
predictive factor for intrahepatic or extrahepatic tumor re-
currence [16]. The number of CTCs detected in post-oper-
ative or post-dissection blood samples was significantly 
higher than that in pre-operative or pre-dissection blood 
samples in patients with curable CRC [17]. These studies 
suggested that surgery causes cancer cells to be shed into 
circulation, which consequently results in worse outcomes. 
However, most of these studies obtained blood samples at 
one or two time-points, such as before and after surgery or 
before and after tumor dissection. We hypothesized that 
detecting mRNA markers in the blood at four different 
time-points (pre-operative, pre-mobilization, post-mobi-
lization, and post-operative) would be more useful to 
identify a relationship between surgical manipulation and 
CTC dissemination. We found that the detection rate of 
mRNAs increased after surgical manipulation compared 
with before mobilization, but decreased postoperatively. 
Our results highlight the unfavorable impact of surgical 
manipulation on the manifestation of CTC mRNA.
During the early development of laparoscopy, the onco-
logical safety of laparoscopic surgery was a main concern 
regarding expansion of the laparoscopic area, although 
laparoscopic surgery showed the same long-term onco-
logical outcome (survival and recurrence) compared with 
that of open surgery. The effect of this technique on CTCs 
has been evaluated in some animal and human studies to 
assess the safety of laparoscopic surgery. Pneumoperito-
neum-induced tumor growth or dissemination of tumor 
cells has been described in experimental animal models 
[18-20]. But, Chen et al. [21] found no elevation in CTCs 
during laparoscopic resection, and Wind et al. [22] found 
that fewer CTCs were observed in laparoscopically oper-
ated patients compared with those who underwent open 
surgery. The authors of the latter study hypothesized that 
the “no-touch isolation” technique, rather than surgical 
modality, was the cause for the lower CTC detection rate in 
the laparoscopy group, because they used the technique Soo Yeun Park, et al.
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only in this group, and not in patients who underwent 
open surgery. The prior study showed no deleterious ef-
fect of laparoscopic surgery on CTC, but that study did not 
compare between open and laparoscopic surgery. There-
fore, we compared the detection of mRNA markers in 
blood between laparoscopic and open surgery in this 
s t u d y .  B o t h  g r o u p s  w e r e  s i milar in clinicopathological 
characteristics (data not shown). Both surgical approaches 
basically used the “no-touch isolation” technique. We hy-
pothesized that the laparoscopic group would show less 
dissemination of CTCs because of the smaller instruments 
used and less hand-touch of the tumor-bearing bowel seg-
ment, which should reduce the release of cancer cells. 
However, surgical modality did not affect mRNA de-
tection rates, and both markers were detected at a similar 
rate during both surgical modalities at the four time- 
points. This result is consistent with the results of Bessa et 
al. [23], who also found no difference in CTC detection 
rates with respect to the surgical approach. This result 
may be partly evidence of the observation that surgical 
modalities (open surgery and laparoscopy) have not 
shown difference in overall and 5-year survival rates [24, 
25].
Several studies have shown that the detection rate of 
cancer cells in the portal or mesenteric veins is higher than 
that in peripheral blood [16,22,26]. The higher detection 
rate of cancer cells in drainage veins is explained by the 
fact that tumor cells are filtered by the action of the liver, 
through which tumor cells must pass before entering the 
systemic venous circulation. Furthermore, the large blood 
volume of the peripheral blood can dilute the concen-
tration of tumor cells [9]. Unlike previous studies, we were 
unable to detect any difference in CTC expression rates be-
tween peripheral and IMV samples. Furthermore, we are 
unable to clearly explain why 8% and 7% of patients 
showed conversion from positive mRNA expression in 
peripheral blood before operation to negative expression 
in mesenteric blood before mobilization and vice versa. It 
is possible that differing concentrations of cancer cells at 
the time of blood aspiration resulted in statistical sam-
pling errors, because the sampled blood may not exactly 
represent the cancer burden from the primary cancer, and 
tumor cells released into the bloodstream may not be a 
continuous process [27]. Moreover, the heterogeneity of 
cancer cells can also affects mRNA expression. These 
problems should be resolved in future studies with ad-
vancement of laboratory techniques.
We found that the clinicopathological characteristics 
did not differ significantly between mRNA marker-pos-
itive patients and -negative patients at the post-mobi-
lization time-point. The mRNA expression rate at the 
post-mobilization time-point tended to increase with ad-
vancing cancer stage, but without statistical significance, 
which may be explained by the low number of patients in-
cluded in the mRNA marker-negative group. An interest-
ing finding of this study was that although the mRNA 
marker detection rate decreased after surgical resection, 
some patients showed continued expression following the 
operation and on the fourth post-operative day. The rela-
tionship between clinicopathologic characteristics and the 
prognostic value of CTCs in CRC has been discussed in 
previous reports. Many of these studies found that peri- 
operative mRNA expression is correlated with aggravated 
cancer stage, but not deteriorated long-term prognosis, 
which has only been demonstrated in a few studies 
[11,15,28]. Significant correlations have been found be-
tween poor disease-free survival or recurrence and the de-
tection of CTCs or markers in samples obtained 2 or more 
days after surgical resection. Chen et al. [21] found that the 
late post-operative CTC level (14 days after resection), but 
not the peri-operative level, was highly related to dis-
ease-free survival rate. Sadahiro et al. [29] also found that 
detecting CTCs in blood samples taken 7 days after cura-
tive resection is an independent factor associated with re-
currence. However, many studies differ in their recom-
mendation of the time-point and method of CTC detection 
to predict patient prognosis. Therefore, the prognostic im-
plications and most suitable methodology for CTC de-
tection remain to be established. Because of our study peri-
od, we were unable to assess the association between 
post-operative detection of CTC markers and prognosis. 
We have been continuously following up our patients and 
will assess the prognostic results after a sufficient fol-
low-up period. Clearly, an international consensus on op-
timal CTC detection methodology and supporting large- 
scale studies are warranted to assess the prognostic im-Surgical manipulation and circulating tumor cell
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plication of CTCs.
In conclusion, we found that surgical manipulation in-
fluenced CTCs and their dissemination during surgical re-
section of primary CRC. This result suggests that surgical 
manipulation plays an important role in the processes in-
volved in detachment of primary tumor cells and their en-
try into systemic circulation. We did not find that the type 
of surgical technique affected CTCs. CTCs were detected 
in some patients after surgical resection, which may be in-
dicative of a poor outcome. Longer follow-up and larger- 
scale studies are warranted to understand the long-term 
effects of peri-operative changes in CTCs.
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